The vendor opportunity at AmerisourceBergen Drug
AmerisourceBergen Drug runs 2,361 total pharmacies, 2,204 of them franchised under the GNP Premier Pharmacy program, concentrated in California (145), Texas (111), Georgia (97), Michigan (90) and North Carolina (89). The FDD makes a financial performance representation. AmerisourceBergen is part of Cencora, giving this system distribution-level scale behind each individual pharmacy.
Who controls software purchasing
AmerisourceBergen's Item 8 Restrictions on Systems require each GNP Premier Pharmacy to run a pharmacy management system chosen from one of the participating industry vendors that connect to AmerisourceBergen's own programs, and to sign a Data Authorization to the Master Program Agreement to enable that connection. The choice of which participating vendor to run sits with the pharmacy, within that approved set — a mixed model rather than a single HQ-designated system.
Tech named in the FDD, and what is actually required
Item 8 requires connectivity to AmerisourceBergen's programs through whichever participating industry vendor's pharmacy management system the pharmacy chooses. It also requires immediate enrollment in Elevate Advanced Features and InSite from ABDC, and, unless ABDC approves otherwise in writing, Change Healthcare as the switch vendor that uploads pharmacy data to InSite. A point-of-sale system is optional, though some programs require one that connects with InSitePOS.
Procurement, renewals, and timing
Item 8 runs on an approved-supplier list for products: brand and generic prescription drugs, OTC and health-and-beauty products, and GNP Private Label Products must come from AmerisourceBergen under a distribution agreement such as a prime vendor agreement, or through an approved group purchasing organization or retail buying group. AmerisourceBergen is currently an approved supplier of those categories itself. The initial term is 5 years, and renewal is automatic in 2-year increments while the pharmacy stays compliant, with either side able to give notice not to renew.
How to read the AmerisourceBergen Drug FDD
The embedded PDF viewer below holds AmerisourceBergen's 2026 Franchise Disclosure Document. For a ranked list of targets like this one, talk to FranCloud.
Ordinary royalty terms
Complete royalty terms are not confirmed.